Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Mast Therapeutics Inc

+ Add to Watchlist

YB4N:GR

0.477 EUR 0.003 0.63%

As of 11:26:25 ET on 02/26/2015.

Snapshot for Mast Therapeutics Inc (YB4N)

Open: 0.484 Day's Range: 0.477 - 0.489 Volume: 0
Previous Close: 0.480 52wk Range: 0.312 - 0.660 1-Yr Rtn: -20.50%

Stock Chart for YB4N

No chart data available.
  • YB4N:GR 0.487
  • 1D
  • 1M
  • 1Y
0.480
Interactive YB4N Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for YB4N

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2300
Est. PEG Ratio -
Market Cap (M EUR) 76.06
Shares Outstanding (M) 159.46
30 Day Average Volume 1,039
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for YB4N

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for YB4N

Mast Therapeutics Inc. is a biopharmaceutical company leveraging the MAST (Molecular Adhesion and Sealant Technology) platform, derived from clinical, nonclinical and manufacturing experience with purified and non-purified poloxamers for serious or life-threatening diseases with significant unmet needs.

Brian M CulleyChief Executive OfficerBrandi L RobertsSenior VP/CFO
Patrick L Keran "Pat"President/COO/SecretaryEdwin L Parsley "Ed"Senior VP/Chief Medical Ofcr
More Company Profile & Key Executives for YB4N

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil